Skip to content
Biogen Pharmachem Industries logo

Biogen Pharmachem Industries

531752 BSE
Price unavailable

Biogen Pharmachem Industries (BIOGEN) share price was ₹0.25 at the 28 Oct 2026 close; market capitalisation ₹26.35 Cr; sector Financial Services. The share price fell 64.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹0.44 Cr, against under ₹0.01 Cr a year earlier and net profit fell 83.6% year on year to ₹0.22 Cr (compared with Jun 2025). Promoters held 0.00% of Biogen Pharmachem Industries in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 51/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹0.25 −0.46 −64.79% 1Y

Key Fundamentals

MicrocapFinanceFinancial Services
Market Cap
₹26.35 Cr
EBITDA
₹1.00 Cr
Return on Equity
0.87%
Debt to Equity
0
Book Value
₹0.94
EPS (TTM)
₹0.00
52W High
₹0.72
52W Low
₹0.23

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Financial Services › Other Financial Services

CRISIL
₹4,696.0038.8334,342 Cr10.500.77%25.25%31.04%4,420 Cr884 Cr
RRP Semiconductor
——10,960 Cr1,266.830.00%-85.77%-48.08%-7 Cr-8 Cr
OnEMI Technology Solutions
₹318.758.785,650 Cr2.160.00%20.96%32.93%2,420 Cr317 Cr
Colab Platforms
—515.002,521 Cr—0.02%0.00%0.00%174 Cr5 Cr
Algoquant Fintech
₹76.3548.022,146 Cr15.970.00%24.84%28.77%259 Cr45 Cr
Biogen Pharmachem Industries (this company)
——26 Cr0.270.00%0.87%0.97%1 Cr-0 Cr
Asset Reconstruction Company (India)
₹129.00————————
GYFTR
₹158.67————————
Median 8 companies₹158.6743.434,086 Cr10.500.00%10.92%14.87%217 Cr25 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

51 Average
Overall score

Data confidence 91/100

Category scores

Quality Average 53
Returns, margins, earnings quality 22% weight
Valuation Strong 67
Cheap vs sector & own history 24% weight
Growth Average 55
Sales & profit trajectory 9% weight
Financial Health Strong 73
Solvency, leverage, coverage 9% weight
Momentum Poor 9
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Stock is trading at 0.29 times its book value

Weaknesses

2
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 1.11% over last 3 years.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bearish

Bearish
12
Neutral
6
Bullish
1

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
117% higher than 3Y

change over 1 year

Net Income Growth
-400% lower than 3Y

change over 1 year

Cash Flow Change
245%

change over 1 year

EBITDA Margin Change
-253%

change over 1 year Operating margin 50% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.75
0
0
0.78
-0.09
0
0
1.35
0
0
0.54
0.58
0.44
Expenses
0.34
0.04
0.03
0.04
0.07
0.35
0.54
0.17
0.2
0.39
0.08
0.94
0.22
Operating Profit
0.41
-0.04
-0.03
0.74
-0.16
-0.35
-0.54
1.18
-0.2
-0.39
0.46
-0.36
0.22
OPM %
54.67%
—
—
94.87%
—
—
—
87.41%
—
—
85.19%
-62.07%
50%
Other Income
0
0.76
0.09
0
0
-0.65
0.23
0
1.54
-0.1
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.41
0.72
0.06
0.74
-0.16
-1
-0.31
1.18
1.34
-0.49
0.46
-0.36
0.22
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
0.41
0.72
0.06
0.74
-0.16
-1
-0.31
1.18
1.34
-0.49
0.46
-0.36
0.22
EPS (₹)
0.01
0.01
0
0.01
0
-0.01
0
0.02
0.01
0
0
0
0
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0.11
0.95
0
1.62
2.47
0
2.38
1.2
2.55
1.56
Expenses
0.04
0.03
0.12
6.72
0.95
0.12
3.22
2.49
0.45
0.45
1.49
1.6
1.63
Operating Profit
-0.04
-0.03
-0.12
-6.61
0
-0.12
-1.6
-0.02
-0.45
1.93
-0.29
0.95
-0.07
OPM %
—
—
—
-6009.09%
0%
—
-98.77%
-0.81%
—
81.09%
-24.17%
37.25%
-4.49%
Other Income
0
0
0
0.05
0
0
0
0.01
0.91
0
0
0.01
-0.1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.1
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.14
-0.03
-0.12
-6.56
0
-0.12
-1.6
-0.01
0.46
1.93
-0.29
0.96
-0.17
Tax %
0%
0%
0%
0%
—
0%
0%
0%
0%
0%
0%
10.42%
—
Net Profit
-0.13
-0.03
-0.12
-6.56
0
-0.12
-1.6
-0.01
0.46
1.93
-0.29
0.86
-0.17
EPS (₹)
0
0
0
-0.09
0
0
-0.02
0
0.01
0.03
0
0.01
0
Div. Payout %
0%
0%
0%
0%
—
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
65.26
65.26
65.26
65.26
65.26
65.26
65.26
65.26
65.26
65.26
65.26
90.26
Reserves
-4.27
-4.3
-4.42
-10.98
-10.99
-9.51
-11.12
-11.13
-10.67
-8.74
26.67
8.83
Borrowings
10
6.21
0.72
0.01
0.63
0.31
0
0
0
0
0
0
Other Liabilities
2.49
1.64
1.69
1.64
2.73
0.03
0.11
0.82
0.24
0.3
0.09
0.31
Total Liabilities
73.48
68.81
63.25
55.93
57.63
56.09
54.25
54.95
54.83
56.82
92.02
99.4
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
43.78
26.69
22.39
3.52
6.25
6.45
9.49
6.95
8.85
5.44
23.84
32.78
Other Assets
29.7
42.12
40.86
52.41
51.38
49.64
44.76
48
45.98
51.38
68.18
66.62
Total Assets
73.48
68.81
63.25
55.93
57.63
56.09
54.25
54.95
54.83
56.82
92.02
99.4
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-7.28
4.68
-0.07
-13.65
0.09
-1.21
3.95
1.4
1.7
1.94
-1.08
1.57
Investing
17.08
17.08
4.3
14.32
-0.72
1.54
-3.64
-1.32
-1.66
-2.06
-32.62
-9.56
Financing
-11.19
-21.74
-4.31
-0.71
0.62
-0.32
-0.31
0
0
0
35.7
6.3
Net Cash Flow
-1.38
0.02
-0.07
-0.03
-0.02
0
0
0.08
0.05
-0.11
2
-1.69
Free Cash Flow
-7.28
4.68
-0.07
-13.65
0.09
-1.21
3.95
1.4
1.7
1.94
-1.08
1.57
CFO/OP
18,200
-15,600
58
207
—
1,008
-247
-7,000
-378
101
372
176
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
23,327
3,085
—
572
0
—
0
0
0
Inventory Days
—
—
—
—
0
—
0
0
—
—
—
—
Cash Conversion Cycle
—
—
—
23,327
3,085
—
572
0
—
0
0
0
Working Capital Days
—
—
—
23,194
2,651
—
550
152
—
-35.27
170
-20.04
ROCE %
-0.15%
-0.04%
-0.19%
-11.32%
0%
-0.22%
-2.9%
-0.02%
-0.37%
3.47%
-0.39%
1.01%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Biogen Pharmachem Industries insights

58 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Public77.27%Others22.73%As ofSep 2026

Documents

Frequently Asked Questions about Biogen Pharmachem Industries

What does Biogen Pharmachem Industries Ltd do?
Incorporated in 1995, Biogen Pharmachem Industries Ltd is in the business of trading in shares and securities.[1]
Where is Biogen Pharmachem Industries Ltd (BIOGEN) listed?
Biogen Pharmachem Industries Ltd trades under code 531752 on the BSE.
Which sector does Biogen Pharmachem Industries Ltd belong to?
Biogen Pharmachem Industries Ltd is classified under the Financial Services sector, in the Other Financial Services industry.
What is the market capitalisation of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd has a market capitalisation of ₹26.35 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Biogen Pharmachem Industries Ltd?
Over the last 52 weeks Biogen Pharmachem Industries Ltd has traded between ₹0.23 and ₹0.72 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd reported a return on equity of 0.87%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1995, Biogen Pharmachem Industries Ltd is in the business of trading in shares and securities.[1]

Website suntechnooverseas.in
Face Value ₹ 1
Shares Outstanding 1,05,41,66,667

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531752.md for Biogen Pharmachem Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More NBFC & Finance stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month